PhRMA’s submission to the Trade Policy Staff Committee of the Executive Office of the President for inclusion in the 2017 National Trade Estimate Report (NTE) outlines the principal trade barriers our member companies face worldwide and identifies concrete actions the U.S. government can take to address these obstacles.